Metabolic fate of indometacin farnesil, a prodrug of indomethacin: characteristic biotransformation of indometacin farnesil in rats. 1990

M Mishima, and S Kobayashi, and S Abe, and C Yamato
Department of Drug Metabolism, Eisai Co., Ltd, Ibaraki, Japan.

1. Hydrolysis of indometacin farnesil (IMF), a farnesyl ester of indomethacin, was higher in plasma and pancreatic juice than in liver and kidney homogenates of rats. Plasma hydrolytic activity was extremely low in beagle dog, monkey and human. 2. Orally administered 14C-IMF was absorbed mainly via the throacic lymph duct and distributed into tissues such as liver, adrenal and spleen as the unchanged from; the 14C in rat plasma was present mainly as indomethacin released from IMF. 3. The concentration ratios of indomethacin in carrageenin-induced inflamed paw to blood after 14C-IMF administration were significantly greater than those after 14C-indomethacin dosing. 4. These results indicate that absorbed IMF might be transported as the unchanged drug into tissues, including the site of inflammation and then hydrolysed to indomethacin in the tissues.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008196 Lymph The interstitial fluid that is in the LYMPHATIC SYSTEM. Lymphs
D008297 Male Males
D010189 Pancreatic Juice The fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum. Juice, Pancreatic,Juices, Pancreatic,Pancreatic Juices
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.

Related Publications

M Mishima, and S Kobayashi, and S Abe, and C Yamato
December 1988, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
April 1996, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
January 1994, Journal of pharmaceutical sciences,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
May 1990, Bratislavske lekarske listy,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
November 1982, Toxicology letters,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
February 1989, Xenobiotica; the fate of foreign compounds in biological systems,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
September 1982, Chemical & pharmaceutical bulletin,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
November 1991, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M Mishima, and S Kobayashi, and S Abe, and C Yamato
October 1965, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!